Minerva Neurosciences
NERV
12 hedge funds and large institutions have $13.6M invested in Minerva Neurosciences in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.97M |
| 2 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
+$1.96M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$1.16M |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$947K |
| 5 |
Goldman Sachs
New York
|
+$307K |
Top Sellers
NERV Hedge Fund Activity: Q3 2014 in Review
12 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2014, worth a combined $13.6M.
Buyers outnumbered sellers: 12 funds opened new NERV positions and 0 closed out — a net gain of 12 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $9.97M.
- 12 institutional investors held Minerva Neurosciences (NERV) as of Q3 2014, up from 0 in Q2 2014.
- Funds reported $13.6M of Minerva Neurosciences stock for Q3 2014.
- 12 funds opened new Minerva Neurosciences positions in Q3 2014 and 0 closed out, a net change of +12 holders.
- The largest Minerva Neurosciences buyer in Q3 2014 was Fidelity Investments, an estimated $9.97M added.
Based on aggregated 13F filings for Q3 2014.